SCHEMBL4252772

SCHEMBL4252772

COc1ccc(/C=C/C(=O)Oc2ccc(/C=C/c3cc(OC(C)=O)cc(OC(C)=O)c3)cc2)cc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.75
KMT2A Q03164 3/20 0.75
KDM4E B2RXH2 3/20 0.75
MAPT P10636 2/20 0.75
TTR P02766 2/20 0.75
LMNA P02545 2/20 0.75
TP53 P04637 1/20 0.75
CYP3A4 P08684 1/20 0.75
SMN1; SMN2 Q16637 1/20 0.75
CYP19A1 P11511 2/20 0.61
TUBB4A P04350 3/20 0.60
TUBB P07437 3/20 0.60
TUBA3C P0DPH7 3/20 0.60
TUBA1B P68363 3/20 0.60
TUBA4A P68366 3/20 0.60
TUBB4B P68371 3/20 0.60
TUBB3 Q13509 3/20 0.60
TUBB2A Q13885 3/20 0.60
TUBB8 Q3ZCM7 3/20 0.60
TUBA3E Q6PEY2 3/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4252780 1.00 MEN1 (0.75) MEN1KMT2AKDM4EMAPTTTR
SCHEMBL4252777 1.00 MEN1 (0.75) MEN1KMT2AKDM4EMAPTTTR
SCHEMBL22315415 0.90 TTR (0.87) MEN1KMT2AKDM4EMAPTTTR
SCHEMBL8082171 0.90 KMT2A (0.75) MEN1KMT2AKDM4EMAPTTTR
SCHEMBL15884198 0.89 TUBB4A (0.72) MEN1KMT2AKDM4EMAPTTTR
SCHEMBL7427989 0.88 TTR (0.84) MEN1KMT2AKDM4EMAPTTTR
SCHEMBL7427998 0.88 TTR (0.84) MEN1KMT2AKDM4EMAPTTTR
SCHEMBL4257210 0.87 JUN (0.64) MEN1KMT2AKDM4EMAPTTTR
SCHEMBL4257208 0.87 JUN (0.64) MEN1KMT2AKDM4EMAPTTTR
SCHEMBL4257202 0.87 JUN (0.64) MEN1KMT2AKDM4EMAPTTTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9067908-B2 Polyphenolic bioprecursors RHODIA CHIMIE (FR) 2015-06-30 US claimed
EP-1893555-B1 POLYPHENOL-BASED BIOPRECURSOR RHODIA CHIMIE SA (FR) 2014-10-29 EP claimed
US-20090215881-A1 Polyphenolic Bioprecursors CHIMIE, Rhodia Chime (FR) 2009-08-27 US claimed
EP-1893555-A1 POLYPHENOL-BASED BIOPRECURSOR RHODIA CHIMIE (FR) 2008-03-05 EP claimed
WO-2006134282-A1 POLYPHENOL-BASED BIOPRECURSOR RHODIA CHIMIE (FR) 2006-12-21 WO claimed
US-9067908-B2 Polyphenolic bioprecursors RHODIA CHIMIE (FR) 2015-06-30 US disclosed
EP-1893555-B1 POLYPHENOL-BASED BIOPRECURSOR RHODIA CHIMIE SA (FR) 2014-10-29 EP disclosed
US-20090215881-A1 Polyphenolic Bioprecursors CHIMIE, Rhodia Chime (FR) 2009-08-27 US disclosed
EP-1893555-A1 POLYPHENOL-BASED BIOPRECURSOR RHODIA CHIMIE (FR) 2008-03-05 EP disclosed
WO-2006134282-A1 POLYPHENOL-BASED BIOPRECURSOR RHODIA CHIMIE (FR) 2006-12-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215881-A1 Polyphenolic Bioprecursors PPARG, PPARA, FABP4 MEN1 4026/4885KMT2A 2120/4885KDM4E 1867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.